Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study

Telomeres Mendelian Randomization Collaboration

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

IMPORTANCE: The causal direction and magnitude of the association between telomere length and incidence of cancer and non-neoplastic diseases is uncertain owing to the susceptibility of observational studies to confounding and reverse causation. OBJECTIVE: To conduct a Mendelian randomization study, using germline genetic variants as instrumental variables, to appraise the causal relevance of telomere length for risk of cancer and non-neoplastic diseases. DATA SOURCES: Genomewide association studies (GWAS) published up to January 15, 2015. STUDY SELECTION: GWAS of noncommunicable diseases that assayed germline genetic variation and did not select cohort or control participants on the basis of preexisting diseases. Of 163 GWAS of noncommunicable diseases identified, summary data from 103 were available. DATA EXTRACTION AND SYNTHESIS: Summary association statistics for single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population. MAIN OUTCOMES AND MEASURES: Odds ratios (ORs) and 95% confidence intervals (CIs) for disease per standard deviation (SD) higher telomere length due to germline genetic variation. RESULTS: Summary data were available for 35 cancers and 48 non-neoplastic diseases, corresponding to 420 081 cases (median cases, 2526 per disease) and 1 093 105 controls (median, 6789 per disease). Increased telomere length due to germline genetic variation was generally associated with increased risk for site-specific cancers. The strongest associations (ORs [95% CIs] per 1-SD change in genetically increased telomere length) were observed for glioma, 5.27 (3.15-8.81); serous low-malignant-potential ovarian cancer, 4.35 (2.39-7.94); lung adenocarcinoma, 3.19 (2.40-4.22); neuroblastoma, 2.98 (1.92-4.62); bladder cancer, 2.19 (1.32-3.66); melanoma, 1.87 (1.55-2.26); testicular cancer, 1.76 (1.02-3.04); kidney cancer, 1.55 (1.08-2.23); and endometrial cancer, 1.31 (1.07-1.61). Associations were stronger for rarer cancers and at tissue sites with lower rates of stem cell division. There was generally little evidence of association between genetically increased telomere length and risk of psychiatric, autoimmune, inflammatory, diabetic, and other non-neoplastic diseases, except for coronary heart disease (OR, 0.78 [95% CI, 0.67-0.90]), abdominal aortic aneurysm (OR, 0.63 [95% CI, 0.49-0.81]), celiac disease (OR, 0.42 [95% CI, 0.28-0.61]) and interstitial lung disease (OR, 0.09 [95% CI, 0.05-0.15]). CONCLUSIONS AND RELEVANCE: It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases.

Original languageEnglish
Pages (from-to)636-651
Number of pages16
JournalJAMA oncology
Volume3
Issue number5
DOIs
Publication statusPublished - 1 Jan 2017
Externally publishedYes

Fingerprint

Telomere
Random Allocation
Odds Ratio
Confidence Intervals
Neoplasms
Preexisting Condition Coverage
Kidney Neoplasms
Interstitial Lung Diseases
Abdominal Aortic Aneurysm
Testicular Neoplasms
Celiac Disease
Endometrial Neoplasms
Neuroblastoma
Urinary Bladder Neoplasms
Glioma
Causality
Cell Division
Ovarian Neoplasms
Observational Studies
Single Nucleotide Polymorphism

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study. / Telomeres Mendelian Randomization Collaboration.

In: JAMA oncology, Vol. 3, No. 5, 01.01.2017, p. 636-651.

Research output: Contribution to journalArticle

Telomeres Mendelian Randomization Collaboration. / Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study. In: JAMA oncology. 2017 ; Vol. 3, No. 5. pp. 636-651.
@article{37e3f4f6ace34ae3aa09fdfde21a24bc,
title = "Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study",
abstract = "IMPORTANCE: The causal direction and magnitude of the association between telomere length and incidence of cancer and non-neoplastic diseases is uncertain owing to the susceptibility of observational studies to confounding and reverse causation. OBJECTIVE: To conduct a Mendelian randomization study, using germline genetic variants as instrumental variables, to appraise the causal relevance of telomere length for risk of cancer and non-neoplastic diseases. DATA SOURCES: Genomewide association studies (GWAS) published up to January 15, 2015. STUDY SELECTION: GWAS of noncommunicable diseases that assayed germline genetic variation and did not select cohort or control participants on the basis of preexisting diseases. Of 163 GWAS of noncommunicable diseases identified, summary data from 103 were available. DATA EXTRACTION AND SYNTHESIS: Summary association statistics for single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population. MAIN OUTCOMES AND MEASURES: Odds ratios (ORs) and 95{\%} confidence intervals (CIs) for disease per standard deviation (SD) higher telomere length due to germline genetic variation. RESULTS: Summary data were available for 35 cancers and 48 non-neoplastic diseases, corresponding to 420 081 cases (median cases, 2526 per disease) and 1 093 105 controls (median, 6789 per disease). Increased telomere length due to germline genetic variation was generally associated with increased risk for site-specific cancers. The strongest associations (ORs [95{\%} CIs] per 1-SD change in genetically increased telomere length) were observed for glioma, 5.27 (3.15-8.81); serous low-malignant-potential ovarian cancer, 4.35 (2.39-7.94); lung adenocarcinoma, 3.19 (2.40-4.22); neuroblastoma, 2.98 (1.92-4.62); bladder cancer, 2.19 (1.32-3.66); melanoma, 1.87 (1.55-2.26); testicular cancer, 1.76 (1.02-3.04); kidney cancer, 1.55 (1.08-2.23); and endometrial cancer, 1.31 (1.07-1.61). Associations were stronger for rarer cancers and at tissue sites with lower rates of stem cell division. There was generally little evidence of association between genetically increased telomere length and risk of psychiatric, autoimmune, inflammatory, diabetic, and other non-neoplastic diseases, except for coronary heart disease (OR, 0.78 [95{\%} CI, 0.67-0.90]), abdominal aortic aneurysm (OR, 0.63 [95{\%} CI, 0.49-0.81]), celiac disease (OR, 0.42 [95{\%} CI, 0.28-0.61]) and interstitial lung disease (OR, 0.09 [95{\%} CI, 0.05-0.15]). CONCLUSIONS AND RELEVANCE: It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases.",
author = "{Telomeres Mendelian Randomization Collaboration} and Haycock, {Philip C.} and Stephen Burgess and Aayah Nounu and Jie Zheng and Okoli, {George N.} and Jack Bowden and Wade, {Kaitlin Hazel} and Timpson, {Nicholas J.} and Evans, {David M.} and Peter Willeit and Abraham Aviv and Gaunt, {Tom R.} and Gibran Hemani and Massimo Mangino and Ellis, {Hayley Patricia} and Kurian, {Kathreena M.} and Pooley, {Karen A.} and Eeles, {Rosalind A.} and Lee, {Jeffrey E.} and Shenying Fang and Chen, {Wei V.} and Law, {Matthew H.} and Bowdler, {Lisa M.} and Iles, {Mark M.} and Qiong Yang and Worrall, {Bradford B.} and Markus, {Hugh Stephen} and Hung, {Rayjean J.} and Amos, {Chris I.} and Spurdle, {Amanda B.} and Thompson, {Deborah J.} and O'Mara, {Tracy A.} and Brian Wolpin and Laufey Amundadottir and Rachael Stolzenberg-Solomon and Antonia Trichopoulou and Onland-Moret, {N. Charlotte} and Eiliv Lund and Duell, {Eric J.} and Federico Canzian and Gianluca Severi and Kim Overvad and Gunter, {Marc J.} and Rosario Tumino and Ulrika Svenson and {Van Rij}, Andre and Baas, {Annette F.} and Bown, {Matthew J.} and Samani, {Nilesh J.} and Steven Hunt",
year = "2017",
month = "1",
day = "1",
doi = "10.1001/jamaoncol.2016.5945",
language = "English",
volume = "3",
pages = "636--651",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study

AU - Telomeres Mendelian Randomization Collaboration

AU - Haycock, Philip C.

AU - Burgess, Stephen

AU - Nounu, Aayah

AU - Zheng, Jie

AU - Okoli, George N.

AU - Bowden, Jack

AU - Wade, Kaitlin Hazel

AU - Timpson, Nicholas J.

AU - Evans, David M.

AU - Willeit, Peter

AU - Aviv, Abraham

AU - Gaunt, Tom R.

AU - Hemani, Gibran

AU - Mangino, Massimo

AU - Ellis, Hayley Patricia

AU - Kurian, Kathreena M.

AU - Pooley, Karen A.

AU - Eeles, Rosalind A.

AU - Lee, Jeffrey E.

AU - Fang, Shenying

AU - Chen, Wei V.

AU - Law, Matthew H.

AU - Bowdler, Lisa M.

AU - Iles, Mark M.

AU - Yang, Qiong

AU - Worrall, Bradford B.

AU - Markus, Hugh Stephen

AU - Hung, Rayjean J.

AU - Amos, Chris I.

AU - Spurdle, Amanda B.

AU - Thompson, Deborah J.

AU - O'Mara, Tracy A.

AU - Wolpin, Brian

AU - Amundadottir, Laufey

AU - Stolzenberg-Solomon, Rachael

AU - Trichopoulou, Antonia

AU - Onland-Moret, N. Charlotte

AU - Lund, Eiliv

AU - Duell, Eric J.

AU - Canzian, Federico

AU - Severi, Gianluca

AU - Overvad, Kim

AU - Gunter, Marc J.

AU - Tumino, Rosario

AU - Svenson, Ulrika

AU - Van Rij, Andre

AU - Baas, Annette F.

AU - Bown, Matthew J.

AU - Samani, Nilesh J.

AU - Hunt, Steven

PY - 2017/1/1

Y1 - 2017/1/1

N2 - IMPORTANCE: The causal direction and magnitude of the association between telomere length and incidence of cancer and non-neoplastic diseases is uncertain owing to the susceptibility of observational studies to confounding and reverse causation. OBJECTIVE: To conduct a Mendelian randomization study, using germline genetic variants as instrumental variables, to appraise the causal relevance of telomere length for risk of cancer and non-neoplastic diseases. DATA SOURCES: Genomewide association studies (GWAS) published up to January 15, 2015. STUDY SELECTION: GWAS of noncommunicable diseases that assayed germline genetic variation and did not select cohort or control participants on the basis of preexisting diseases. Of 163 GWAS of noncommunicable diseases identified, summary data from 103 were available. DATA EXTRACTION AND SYNTHESIS: Summary association statistics for single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population. MAIN OUTCOMES AND MEASURES: Odds ratios (ORs) and 95% confidence intervals (CIs) for disease per standard deviation (SD) higher telomere length due to germline genetic variation. RESULTS: Summary data were available for 35 cancers and 48 non-neoplastic diseases, corresponding to 420 081 cases (median cases, 2526 per disease) and 1 093 105 controls (median, 6789 per disease). Increased telomere length due to germline genetic variation was generally associated with increased risk for site-specific cancers. The strongest associations (ORs [95% CIs] per 1-SD change in genetically increased telomere length) were observed for glioma, 5.27 (3.15-8.81); serous low-malignant-potential ovarian cancer, 4.35 (2.39-7.94); lung adenocarcinoma, 3.19 (2.40-4.22); neuroblastoma, 2.98 (1.92-4.62); bladder cancer, 2.19 (1.32-3.66); melanoma, 1.87 (1.55-2.26); testicular cancer, 1.76 (1.02-3.04); kidney cancer, 1.55 (1.08-2.23); and endometrial cancer, 1.31 (1.07-1.61). Associations were stronger for rarer cancers and at tissue sites with lower rates of stem cell division. There was generally little evidence of association between genetically increased telomere length and risk of psychiatric, autoimmune, inflammatory, diabetic, and other non-neoplastic diseases, except for coronary heart disease (OR, 0.78 [95% CI, 0.67-0.90]), abdominal aortic aneurysm (OR, 0.63 [95% CI, 0.49-0.81]), celiac disease (OR, 0.42 [95% CI, 0.28-0.61]) and interstitial lung disease (OR, 0.09 [95% CI, 0.05-0.15]). CONCLUSIONS AND RELEVANCE: It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases.

AB - IMPORTANCE: The causal direction and magnitude of the association between telomere length and incidence of cancer and non-neoplastic diseases is uncertain owing to the susceptibility of observational studies to confounding and reverse causation. OBJECTIVE: To conduct a Mendelian randomization study, using germline genetic variants as instrumental variables, to appraise the causal relevance of telomere length for risk of cancer and non-neoplastic diseases. DATA SOURCES: Genomewide association studies (GWAS) published up to January 15, 2015. STUDY SELECTION: GWAS of noncommunicable diseases that assayed germline genetic variation and did not select cohort or control participants on the basis of preexisting diseases. Of 163 GWAS of noncommunicable diseases identified, summary data from 103 were available. DATA EXTRACTION AND SYNTHESIS: Summary association statistics for single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population. MAIN OUTCOMES AND MEASURES: Odds ratios (ORs) and 95% confidence intervals (CIs) for disease per standard deviation (SD) higher telomere length due to germline genetic variation. RESULTS: Summary data were available for 35 cancers and 48 non-neoplastic diseases, corresponding to 420 081 cases (median cases, 2526 per disease) and 1 093 105 controls (median, 6789 per disease). Increased telomere length due to germline genetic variation was generally associated with increased risk for site-specific cancers. The strongest associations (ORs [95% CIs] per 1-SD change in genetically increased telomere length) were observed for glioma, 5.27 (3.15-8.81); serous low-malignant-potential ovarian cancer, 4.35 (2.39-7.94); lung adenocarcinoma, 3.19 (2.40-4.22); neuroblastoma, 2.98 (1.92-4.62); bladder cancer, 2.19 (1.32-3.66); melanoma, 1.87 (1.55-2.26); testicular cancer, 1.76 (1.02-3.04); kidney cancer, 1.55 (1.08-2.23); and endometrial cancer, 1.31 (1.07-1.61). Associations were stronger for rarer cancers and at tissue sites with lower rates of stem cell division. There was generally little evidence of association between genetically increased telomere length and risk of psychiatric, autoimmune, inflammatory, diabetic, and other non-neoplastic diseases, except for coronary heart disease (OR, 0.78 [95% CI, 0.67-0.90]), abdominal aortic aneurysm (OR, 0.63 [95% CI, 0.49-0.81]), celiac disease (OR, 0.42 [95% CI, 0.28-0.61]) and interstitial lung disease (OR, 0.09 [95% CI, 0.05-0.15]). CONCLUSIONS AND RELEVANCE: It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases.

UR - http://www.scopus.com/inward/record.url?scp=85019502119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019502119&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2016.5945

DO - 10.1001/jamaoncol.2016.5945

M3 - Article

C2 - 28241208

AN - SCOPUS:85019502119

VL - 3

SP - 636

EP - 651

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

IS - 5

ER -